Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorised
August 5, 2021

Coronavirus company news summary – EC makes advance order for 200m doses of Novavax Covid-19 vaccine – WHO calls for pause on vaccine boosters until end of September at earliest

By Chris Lo

The European Commission (EC) has finalised an advance purchase agreement for up to 200 million doses of Novavax’s recombinant nanoparticle protein-based Covid-19 vaccine, NVX-CoV2373. The deal is for the acquisition of up to 100 million doses and an option for another 100 million doses through 2023. Novavax is currently progressing its rolling submission for the vaccine to the European Medicines Agency (EMA) in the third quarter of this year and the delivery of the first doses will start after approval.

The World Health Organization has called for a moratorium on Covid-19 vaccine boosters until the end of September at least, in a bid to boost vaccine supplies to low-income countries. The aim is to allow a minimum of 10% of each country’s population to be inoculated. WHO director-general Tedros Adhanom Ghebreyesus noted that high-income nations have administered nearly 100 doses for every 100 people so far while low-income nations only administered 1.5 doses for every 100 people due to a lack of supply.

NRx Pharmaceuticals has partnered with MannKind to develop a dry powder formulation of  Zyesami, which secured the US Food and Drug Administration’s fast track designation in acute lung injury or acute respiratory distress syndrome caused by Covid-19. In a Phase IIb/III trial, the drug was able to increase survival chances in Covid-19 patients with respiratory failure.

Related Companies

Content from our partners
Extractables and leachables analysis in pharmaceutical quality control
How Hengst helped to keep Germany’s charity “star singers” shining
Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU